Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid

被引：1
作者：
Leisti, Paivi [1 ,2 ]
Pankakoski, Anna [3 ,4 ]
Jokelainen, Jari [5 ]
Huilaja, Laura [1 ,2 ]
Panelius, Jaana [3 ,4 ]
Tasanen, Kaisa [1 ,2 ]
Varpuluoma, Outi [1 ,2 ]
机构：
[1] Oulu Univ Hosp, Med Res Ctr Oulu, Dept Dermatol, Res Unit Clin Med, Aapistie 5 A, FIN-90220 Oulu, Finland
[2] Univ Oulu, Aapistie 5 A, Oulu 90220, Finland
[3] Univ Helsinki, Dept Dermatol & Allergol, Helsinki, Finland
[4] Helsinki Univ Hosp, Helsinki, Finland
[5] Univ Oulu, Infrastruct Populat Studies, Oulu, Finland
来源：
ACTA DERMATO-VENEREOLOGICA | 2024年 / 104卷
基金：
芬兰科学院;
关键词：
Bullous pemphigoid; dipeptidyl-4; peptidase; epidemiology; gliptin; mortality;
D O I：
10.2340/actadv.v104.40645
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [21] A Comparison for Type 2 Cytokines and Lesional Inflammatory Infiltrations in Bullous Pemphigoid and Atopic Dermatitis
    Hu, Yu-qing
    Zhang, Jian-zhong
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 2313 - 2321
  • [22] Sarcopenia Is Associated With a Risk of Mortality in People With Type 2 Diabetes Mellitus
    Takahashi, Fuyuko
    Hashimoto, Yoshitaka
    Kaji, Ayumi
    Sakai, Ryosuke
    Okamura, Takuro
    Kitagawa, Noriyuki
    Okada, Hiroshi
    Nakanishi, Naoko
    Majima, Saori
    Senmaru, Takafumi
    Ushigome, Emi
    Hamaguchi, Masahide
    Asano, Mai
    Yamazaki, Masahiro
    Fukui, Michiaki
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [23] Generalized immunosuppression-associated type Kaposi's sarcoma in a patient with severe refractory bullous pemphigoid
    Cheng, Teh-Yang
    Hsiao, Cheng-Hsiang
    Chu, Chia-Yu
    DERMATOLOGICA SINICA, 2008, 26 (02) : 85 - 92
  • [24] Extracellular cleavage of bullous pemphigoid antigen 180 type XVII collagen and its involvement in hemidesmosomal disassembly
    Hirako, Y
    Yoshino, K
    Zillikens, D
    Owaribe, K
    JOURNAL OF BIOCHEMISTRY, 2003, 133 (02) : 197 - 206
  • [25] Treatment of refractory bullous pemphigoid with IFN-α-2b: A case report
    Wang, Tianjing
    Xu, Yingping
    Ren, Yingying
    Luo, Guangpu
    DERMATOLOGIC THERAPY, 2020, 33 (02)
  • [26] Dipeptidyl peptidase-4 inhibitors-associated bullous pemphigoid: A retrospective study of 168 pemphigoid and 9,304 diabetes mellitus patients
    Kawaguchi, Yohei
    Shimauchi, Risa
    Nishibori, Nobuhiro
    Kawashima, Kiyohito
    Oshitani, So
    Fujiya, Atsushi
    Shibata, Taiga
    Ohashi, Norimi
    Izumi, Kentaro
    Nishie, Wataru
    Shimizu, Hiroshi
    Arima, Hiroshi
    Sobajima, Hiroshi
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) : 392 - 398
  • [27] Serum inflammatory biomarkers associated with disease severity and response to dupilumab treatment in bullous pemphigoid: A cluster analysis
    Li, Jiaqi
    Chen, Xixue
    Zhu, Xuejun
    Shang, Panpan
    Wang, Mingyue
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2024, 116 (01) : 24 - 33
  • [28] Oral diabetes medications other than dipeptidyl peptidase 4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study
    Varpuluoma, Outi
    Forsti, Anna-Kaisa
    Jokelainen, Jari
    Turpeinen, Miia
    Timonen, Markku
    Tasanen, Kaisa
    Huilaja, Laura
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (06) : 1034 - +
  • [29] Temporal Trends in Mortality Associated with Comorbid Type 2 Diabetes and Schizophrenia: The Fremantle Diabetes Study
    Davis, Wendy A.
    Bruce, David G.
    Starkstein, Sergio E.
    Davis, Timothy M. E.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [30] Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study
    Mantovani, Alessandro
    Busti, Fabiana
    Borella, Nicolo
    Scoccia, Enrico
    Pecoraro, Barbara
    Sani, Elena
    Morandin, Riccardo
    Csermely, Alessandro
    Piasentin, Daniele
    Grespan, Elisabetta
    Castagna, Annalisa
    Bilson, Josh
    Byrne, Christopher D.
    Valenti, Luca
    Girelli, Domenico
    Targher, Giovanni
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
12345